Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19441235rdf:typepubmed:Citationlld:pubmed
pubmed-article:19441235lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:19441235lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:19441235lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:19441235lifeskim:mentionsumls-concept:C0162768lld:lifeskim
pubmed-article:19441235lifeskim:mentionsumls-concept:C2248769lld:lifeskim
pubmed-article:19441235lifeskim:mentionsumls-concept:C0054889lld:lifeskim
pubmed-article:19441235lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:19441235lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:19441235pubmed:issue1lld:pubmed
pubmed-article:19441235pubmed:dateCreated2009-5-15lld:pubmed
pubmed-article:19441235pubmed:abstractTextWe constructed the eukaryotic expression vector of human IL-35-IgG4 (Fc)-pOptiVEC-TOPO by gene recombination technique and expressed the fusion protein human IL-35-IgG4 (Fc) in CHO/DG44 cells. The two components of the newly discovered cytokine human IL-35, EBI3 and IL-12p35, were amplified by PCR from the cDNA library derived from the KG-I cells after LPS induction. The two PCR-amplified cDNA fragments of human IL-35 were linked by over-lapping PCR and then cloned into the IgG4 (Fc)-pOptiVEC-TOPO vector. The constructed plasmid with the recombinant cDNA IL-35-IgG4 (Fc) was verified by restriction enzyme digestion analysis, PCR and DNA sequencing. The verified plasmid with the recombinant cDNA was transfected into CHO/DG44 cells using Lipofectamine 2000. The success of the transfection was examined and confirmed by RT-PCR. After selection in alpha-MEM (-) medium, the IL-35-Ig G4 (Fc) positive CHO/DG44 clones were chosen and the media from these positive clones were collected to be used to purify the fusion protein. The positive CHO/DG44 clones were further cultured in increasing concentrations of MTX and the expression levels of the fusion protein IL-35-Ig G4 (Fc) were repetitively induced by MTX-induced gene amplification. The IL-35-IgG4 (Fc) fusion protein was purified from the media collected from the positive CHO/DG44 clones by protein G affinity chromatography and then identified by SDS-PAGE and Western blotting. The results showed that one protein band was found to match well with the predicted relative molecular mass of human IL-35-IgG4 (Fc) and this protein could specifically bind to anti-human IgG4 (Fc) monoclonal antibody. In conclusion, our study successfully established an IL-35-IgG4 (Fc) positive DG44 cell line which could stably express IL-35-IgG4 (Fc) fusion protein.lld:pubmed
pubmed-article:19441235pubmed:languagechilld:pubmed
pubmed-article:19441235pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19441235pubmed:citationSubsetIMlld:pubmed
pubmed-article:19441235pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19441235pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19441235pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19441235pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19441235pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19441235pubmed:statusMEDLINElld:pubmed
pubmed-article:19441235pubmed:monthJanlld:pubmed
pubmed-article:19441235pubmed:issn1000-3061lld:pubmed
pubmed-article:19441235pubmed:authorpubmed-author:XiaZ FZFlld:pubmed
pubmed-article:19441235pubmed:authorpubmed-author:GaoWendaWlld:pubmed
pubmed-article:19441235pubmed:authorpubmed-author:ZhangQingQlld:pubmed
pubmed-article:19441235pubmed:authorpubmed-author:ChenYangYlld:pubmed
pubmed-article:19441235pubmed:authorpubmed-author:ZhangDaweiDlld:pubmed
pubmed-article:19441235pubmed:authorpubmed-author:TangJingJlld:pubmed
pubmed-article:19441235pubmed:authorpubmed-author:LiuQuanshengQlld:pubmed
pubmed-article:19441235pubmed:issnTypePrintlld:pubmed
pubmed-article:19441235pubmed:volume25lld:pubmed
pubmed-article:19441235pubmed:ownerNLMlld:pubmed
pubmed-article:19441235pubmed:authorsCompleteYlld:pubmed
pubmed-article:19441235pubmed:pagination109-15lld:pubmed
pubmed-article:19441235pubmed:meshHeadingpubmed-meshheading:19441235...lld:pubmed
pubmed-article:19441235pubmed:meshHeadingpubmed-meshheading:19441235...lld:pubmed
pubmed-article:19441235pubmed:meshHeadingpubmed-meshheading:19441235...lld:pubmed
pubmed-article:19441235pubmed:meshHeadingpubmed-meshheading:19441235...lld:pubmed
pubmed-article:19441235pubmed:meshHeadingpubmed-meshheading:19441235...lld:pubmed
pubmed-article:19441235pubmed:meshHeadingpubmed-meshheading:19441235...lld:pubmed
pubmed-article:19441235pubmed:meshHeadingpubmed-meshheading:19441235...lld:pubmed
pubmed-article:19441235pubmed:meshHeadingpubmed-meshheading:19441235...lld:pubmed
pubmed-article:19441235pubmed:meshHeadingpubmed-meshheading:19441235...lld:pubmed
pubmed-article:19441235pubmed:meshHeadingpubmed-meshheading:19441235...lld:pubmed
pubmed-article:19441235pubmed:meshHeadingpubmed-meshheading:19441235...lld:pubmed
pubmed-article:19441235pubmed:meshHeadingpubmed-meshheading:19441235...lld:pubmed
pubmed-article:19441235pubmed:year2009lld:pubmed
pubmed-article:19441235pubmed:articleTitle[Expression of human IL-35-IgG4 (Fc) fusion protein in CHO/DG44 cells].lld:pubmed
pubmed-article:19441235pubmed:affiliationCollege of Life Science, Sichuan University, Chengdu 610041, China.lld:pubmed
pubmed-article:19441235pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19441235pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:19441235pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed